Update on liver disease in hemophilia patients

Seminars in Hematology

Volumn 43, Issue SUPPL. 1, 2006, Pages

  Kessler, Craig M ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; CHEMOKINE RECEPTOR CCR5; PEGINTERFERON; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIBAVIRIN; RIBAVIRIN DERIVATIVE;

BLOOD TRANSFUSION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTIVIRAL AGENTS; FACTOR VII; HEMOPHILIA A; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; RECOMBINANT PROTEINS; RIBAVIRIN;

EID: 31444449425     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2005.11.021     Document Type: Conference Paper

References (45)

1. M. Morfini, P.M. Mannucci, N. Ciavarella, M. Schiavoni, A. Gringeri, D. Rafanelli Prevalence of infection with hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates A retrospective evaluation Vox Sang 67 1994 178 182
2. D.B. Brettler, H.J. Alter, J.L. Dienstag, A.D. Forsberg, P.H. Levine Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients Blood 76 1990 254 256
3. M.E. Eyster, K.E. Sherman, J.J. Goedert, A. Katsoulidou, A. Hatzakis Prevalence and changes in hepatitis C virus genotype among multitransfused persons with haemophilia. The Multicenter Hemophilia Cohort Study J Infect Dis 179 1999 1062 1069
4. T.T. Yee, A. Griffioen, C.A. Sabin, G. Dusheiko, C.A. Lee The natural history of HCV in a cohort of haemophiliac patients infected between 1961 and 1985 Gut 47 2000 845 851
5. C. Lee, G. Dusheiko The natural history and antiviral treatment of hepatitis C in haemophilia Haemophilia 8 2002 322 329
6. M. Franchini, G. Rossetti, A. Tagliaferri, F. Capra, E. de Maria, C. Pattacini The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders Blood 98 2001 1836 1841
7. B.L. Kroner, P.S. Rosenberg, L.M. Aledort, W.G. Alvord, J.J. Goedert HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study J Acquir Immune Defic Syndr 7 1994 279 286
8. M.V. Ragni, S.H. Belle Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with haemophilia and hepatitis C virus infection J Infect Dis 183 2001 1112 1115
9. M. Colombo, P.M. Mannucci, D.B. Brettler, A. Girolami, E.C.Y. Lian, F. Rodeghiero Hepatocellular carcinoma in hemophilia Am J Hematol 37 1991 243 246
10. E. Santagostino, M. Colombo, M. Rivi, M.G. Rumi, A. Rocino, S. Linari Study Group of the Association of Italian Hemophilia Centers A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus Blood 102 2003 78 82
11. F. Tradati, M. Colombo, P.M. Mannucci, M.G. Rumi, C. De Fazio, G. Gamba The Study Group of the Association of Italian Hemophilia Centers A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C Blood 91 1998 1173 1177
12. F.H. Gordon, P.K. Mistry, C.A. Sabin, C.A. Lee Outcome of orthotopic liver transplantation in patients with haemophilia Gut 42 1998 744 749
13. Y. Sugawara, T. Ohkubo, M. Makuuchi, S. Kimura, Y. Morisawa, N. Tachikawa Living-donor liver transplantation in an HIV-positive patient with hemophilia Transplantation 74 2002 1655 1656
14. A.A. Ashrani, M.T. Reding, A. Shet, J. Osip, A. Humar, J.R. Lake Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor Haemophilia 10 2004 735 737
15. L.M. Aledort, P.H. Levine, M. Hilgartner, P. Blatt, J.A. Spero, J.D. Goldberg A study of liver biopsies and liver disease among hemophiliacs Blood 66 1985 367 372
16. M.M. Ahmed, D.J. Mutimer, E. Elias, J. Linin, M. Garrido, S. Hubscher A combined management protocol for patients with coagulation disorders infected with hepatitis C virus Br J Haematol 95 1996 383 388
17. J.P. Hanley, L.M. Jarvis, J. Andrews, R. Dennis, R. Lee, P. Simmonds Investigation of chronic hepatitis C infection in individuals with haemophilia assessment of invasive and non-invasive methods Br J Haematol 94 1996 159 165
18. M. Makris, F.E. Preston, F.R. Rosendaal, J.C. Underwood, K.M. Rice, D.R. Triger The natural history of chronic hepatitis C in haemophiliacs Br J Haematol 94 1996 746 752
19. R. Gupta, E.M. Druy, C.M. Kessler Safety and potential usefulness of liver biopsy in HIV-seropositive haemophiliacs employing a transjugular venous approach Haemophilia 3 1997 201 204
20. V.S. Wong, T. Baglin, E. Beacham, D.D. Wight, J. Petrik, G.J. Alexander The role for liver biopsy in haemophiliacs infected with the hepatitis C virus Br J Haematol 97 1997 343 347
21. Y. Fukuda, I. Nakano, Y. Katano, H. Toyoda, M. Imoto, J. Takamatsu Assessment and treatment of liver disease in Japanese haemophilia patients Haemophilia 4 1998 595 600
22. A. Venkataramani, C. Behling, R. Rond, C. Glass, K. Lyche Liver biopsies in adult hemophiliacs with hepatitis C A United States center's experience Am J Gastroenterol 95 2000 2374 2376
23. C. McMahon, R. Pilkington, E.O. Shea, D. Kelleher, O.P. Smith Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders Br J Haematol 109 2000 354 359
24. S. Lethagen, A. Widell, E. Berntorp, H. Verbaan, S. Lindgren Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease Br J Haematol 113 2001 87 93
25. D.M. DiMichele, G. Mirani, P. Wilfredo Canchis, D.W. Trost, A.H. Talal Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection Haemophilia 9 2003 613 618
26. J.L. Shin, J. Teitel, M.G. Swain, V.G. Bain, P.C. Adams, K. Croitoru Virology and Immunology Committee of the Association of Hemophilia Clinic Directors of Canada. A Canadian multicentre retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful? Am J Hematol 78 2005 85 93
27. D. Theodore, M.W. Fried, D.E. Kleiner, B.L. Kroner, J.J. Goedert, M.E. Eyster Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C Haemophilia 10 2004 413 421
28. N. Stieltjes, N. Ounnoughene, E. Sava, P. Paugy, V. Roussel-Robert, A.R. Rosenberg Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus Br J Haematol 125 2004 769 776
29. M. Zhang, T.R. O'Brien, W.C. Kopp, J.J. Goedert Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection A nested cross-sectional study BMC Blood Disord 5 2005 2
30. R.P. Woitas, G. Ahlenstiel, A. Iwan, J.K. Rockstroh, H.H. Brackmann, B. Kupfer Frequency of the HIV-protective CC chemokine receptor 5-Δ32/Δ32 genotype is increased in hepatitis C Gastroenterology 122 2002 1721 1728
31. M. Zhang, J.J. Goedert, T.R. O'Brien High frequency of CCR5-Δ32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1 Gastroenterology 124 2003 867 868
32. F. Imbert-Bismut, V. Ratziu, L. Pieroni, F. Charlotte, Y. Benhamou, T. Poynard MULTIVIRC Group Biochemical markers of liver fibrosis in patients with hepatitis C infection A prospective study Lancet 357 2001 1069 1075
33. T. Poynard, F. Imbert-Bismut, M. Munteanu, D. Messous, R.P. Myers, D. Thabut Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C Comp Hepatol 3 2004 8
34. J.J. Goedert, D.L. Brown, K. Hoots, K.E. Sherman Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia Haemophilia 10 suppl 4 2004 205 210
35. F. Carrat, F. Bani-Sadr, S. Pol, E. Rosenthal, F. Lunel-Fabiani, A. Benzekri ANRS HCO2 RIBAVIC Study Team Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients A randomized controlled trial JAMA 292 2004 2839 2848
36. T. Honda, H. Toyoda, K. Hayashi, Y. Katano, M. Yano, I. Nakano Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C JAMA 293 2005 1190 1192
37. E. De Clercq Antiviral drugs current state of the art J Clin Virol 22 2001 73 89
38. R. Dolin, R.C. Reichman, H.P. Madore, R. Maynard, P.N. Linton, J. Webber-Jones A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection N Engl J Med 307 1982 580 584
39. A. Mangia, G.L. Ricci, M. Persico, N. Minerva, V. Carretta, D. Bacca A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naive patients with chronic hepatitis C J Virol Hepat 12 2005 292 299
40. D. Barnard Viramidine (Ribapharm) Curr Opin Invest Drugs 3 2002 1585 1589
41. H. Hinrichsen, Y. Benhamou, H. Wedemeyer, M. Reiser, R.E. Sentjens, J.L. Calleja Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients Gastroenterology 127 2004 1347 1355
42. A. Carvalho, J. Leitao, E. Louro, R. Maia, C. Geraldes, C. Ventura Small dose of recombinant factor VIIa (rFVIIa) to perform percutaneous liver biopsies in cirrhotic patients Rev Esp Enferm Dig 94 2002 280 285
43. L. Jureczko, M. Kolacz, J. Trzebicki, G. Szyszko, M. Pacholczyk, B. Lagiewska Perioperative use of recombinant activated factor VII in liver transplantation Ann Transplant 8 2003 40 42
44. J.P. Lodge, S. Jonas, R.M. Jones, M. Olausson, J. Mir-Pollard, S. Soefelt Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation Liver Transpl 11 2005 973 979
45. R.M. Planinsic, J. van den Meer, G. Testa, L. Grande, A. Candela, R.J. Porte Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease Liver Transpl 11 2005 895 900